Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.11M | 69.39M | 70.91M | 70.91M | 72.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.11M | 69.39M | 70.91M | 70.91M | 72.11M |
| Cost of Revenue | 43.28M | 41.03M | 43.17M | 43.17M | 42.83M |
| Gross Profit | 28.83M | 28.36M | 27.75M | 27.75M | 29.27M |
| SG&A Expenses | 23.54M | 23.61M | 40.26M | 40.26M | 24.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -903.00K | 93.00K | -760.00K | -760.00K | -1.16M |
| Total Operating Expenses | 65.92M | 64.73M | 82.67M | 82.67M | 65.99M |
| Operating Income | 6.20M | 4.66M | -11.75M | -11.75M | 6.12M |
| Income Before Tax | 41.35M | 54.26M | -34.53M | -34.53M | -36.03M |
| Income Tax Expenses | 6.89M | 43.00K | 594.00K | 594.00K | -1.57M |
| Earnings from Continuing Operations | 34.46M | 54.21M | -35.13M | -35.13M | -34.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.46M | 54.21M | -35.13M | -35.13M | -34.46M |
| EBIT | 6.20M | 4.66M | -11.75M | -11.75M | 6.12M |
| EBITDA | 10.12M | 8.56M | -10.83M | -10.83M | 9.89M |
| EPS Basic | 0.07 | 0.12 | -0.07 | -0.07 | -0.07 |
| Normalized Basic EPS | 0.05 | 0.08 | -0.04 | -0.04 | -0.05 |
| EPS Diluted | 0.07 | 0.12 | -0.07 | -0.07 | -0.07 |
| Normalized Diluted EPS | 0.05 | 0.08 | -0.04 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 492.24M | 451.78M | 501.79M | 501.79M | 492.26M |
| Average Diluted Shares Outstanding | 492.24M | 451.78M | 501.79M | 501.79M | 492.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |